Extremely popular vitamin supplements sold nationwide recalled due to 'life-threatening' risk
Popular B12 vitamins sold at ALDI have been recalled due to 'undeclared' peanuts.
New York-based Vita Warehouse Corp is voluntarily recalling one lot of Welby brand Vitamin B12 Energy Support gummy product 1000 mcg 140 gummies, Berkely Jensen Vitamin B12 1000 mcg 250 Gummies and VitaGlobe Vitamin B12 Extra Strength 60 Gummies, the FDA announced Monday.
The recall was initiated after ALDI, which operates 2,500 stores in the US, conducted routine testing to verify the accuracy of its 'allergen-free' labels. One of the test results indicated the potential presence of a peanut allergen.
Internal testing by the manufacturer verified the absence of peanuts, but the company still issued a recall out of an abundance of caution.
It's unclear how many bottles of vitamin B12 supplements were included in the recalled lot.
The products were sold at ALDI and BJ's stores nationwide, as well as Amazon.
The FDA said in its announcement: 'People with an allergy or severe sensitivity to peanuts run the potential risk of serious or life-threatening allergic reactions if they consume these products.'
No illnesses have been reported, and the FDA has not yet assigned a classification to the recall. However, the agency could label it 'Class I' due to the life-threatening risk.
A Class I recall describes 'a situation in which there is a reasonable probability that the use of, or exposure to, a violative product will cause serious adverse health consequences or death,' according to the FDA.
Peanut allergens are one of the leading triggers of anaphylaxis, a severe allergic reaction that causes the immune system to release a flood of antibodies to ward off the foreign invader.
This causes skin reactions like hives, low blood pressure, dizziness, fainting, and the airways to close in and restrict breathing.
Just over 6million Americans are allergic to peanuts, making up two percent of the population, most of whom are children.
Experts estimate 150 to 200 Americans die from food allergies every year due to anaphylaxis, a severe allergic reaction that causes the immune system to release a flood of antibodies to ward off the foreign invader.
About one in four Americans report taking vitamins with B12, which plays a crucial role in forming red blood cells, which help deliver oxygen throughout the body.
It is also thought to support brain and DNA health.
Recalled supplements with VitaGlobe (left) and Berkley Jensen labels are pictured above
The Aldi Welby bottles are clear with a white cap and have green, red and white labeling. The UPC code is 4099100290868.
Berkley Jensen supplements are in a clear bottle with a white cap and use red and pink labeling. The UPC code is 888670132487.
VitaGlobe has a clear bottle with a white cap and white and red labeling. The UPC code is 850005214670.
All products have the lot number 248046601 and an expiration date of October 2026.
The FDA urged customers who are allergic to peanuts and have purchased the products to return them to where they bought them for a full refund or discard them immediately. Consumers who suffer an allergic reaction should seek medical help immediately.
Consumers with questions can contact the company at 1-855-214-0100 Monday-Friday from 7:30am – 4pm EST.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Independent
22 minutes ago
- The Independent
Four sick across two states as health officials warn of salmonella tied to pistachio spread
A salmonella outbreak has left four people sick and health officials warning about a dessert spread. Three people in Minnesota and one in New Jersey fell ill between March 10 and May 19, including one person who was hospitalized. The outbreak is tied to Emek brand pistachio cream with a use-by date of Oct. 19, according to the Centers for Disease Control and cream, a nut butter spread, is used in desserts and other dishes, federal health officials said Monday. The spread, which may be packaged in 11-pound tubs, was imported from Turkey and sold online to wholesale distributors, restaurants and food service locations nationwide. It has a production code of 241019. The product should not be sold, distributed or served, the CDC said. Symptoms of salmonella poisoning can occur within hours or days of consuming contaminated food and include diarrhea, fever and stomach cramps. Most people recover within a week, but some can become sick enough to be hospitalized. Young children, people older than 65 and those with weakened immune systems are most at risk. According to the CDC, Salmonella is responsible for 1.35 million infections each year. Of those, about 26,500 are hospitalized and 420 are killed annually. Roughly 23 percent of Salmonella cases come from eating chicken and turkey.
Daily Mail
44 minutes ago
- Daily Mail
Doctors sound alarm on cancer surging in young men that 90% don't know about
Doctors are sounding the alarm over a lack of awareness about a cancer that is rising quickly among young men. Testicular cancer is the most common form of the disease among men aged 20 to 40 years, and affects nearly 10,000 men every year. But an Ohio State University survey shows that almost 90 percent that the cancer is most likely to strike before a man's 40th birthday. And only 35 percent said they would consider it necessary to start screening for the disease before this age. That's despite the cancer — that affects one in 270 young men every year — becoming more common in young men. The researchers say the findings are concerning, given the disease is more difficult to treat when it is caught in later stages. Dr Shawn Dason, the urologist who led the study, said: 'Testicular cancer does not typically come with painful symptoms. That's why routine self-exams are so important to detect any lumps or changes to the testicle.' He added: 'In my experience, a lot of men are surprised that testicular cancer is most common among young men. 'It's something you're just not expecting in your twenties or thirties. A lot of young men's focus might be on developing their career, their day-to-day life. That's a very different track of mind than perhaps your health.' For the survey, researchers questioned 1,008 adults in the US — of whom just under half were men while the rest were women. Half were also under the age of 40. Results showed that just over half of respondents said it was important to carry out monthly checks for the cancer. Only 13 percent said that testicular cancer was most commonly affecting men under 30 years old. Meanwhile, 63 percent correctly noted the disease was more likely to be curable if it was caught early, and 18 percent wrongly suggested the disease was always painful. The most common symptoms of the disease include a lump or swelling in the scrotum or a feeling of heaviness in the scrotum. Overall, the cancer has a five-year survival rate of about 95 percent if it is caught in the early stages before it has spread in the body. If it spreads, however, this drops to 73 percent. Dr Dason added: 'We are really fortunate in testicular cancer that the vast majority of patients are diagnosed at an early stage. 'That means the vast majority of patients are actually diagnosed before the cancer has had an opportunity to spread to other parts of the body.' It's thought that testicular cancer affects younger men because it predominantly affects the germ cells, or the reproductive cells that make sperm, which are most active at this age. Studies suggest that people who are taller, from a White ethnic background and have a family history of the disease have a higher risk, although some studies suggest that being overweight does not raise the risk. And rates are now rising, which is now thought to be due to a mixture of better screening and linked to the broader rises in cancer diagnoses among young people. A 2024 study on testicular cancer in California found that, among those under 39 years old, the rate of the cancers had risen by about 10 percent in two decades from six to 7.3 cases per 100,000 people. Data from the CDC also shows an uptick in testicular cancer cases in the age group, with the rate rising from 6.3 to 6.8 cases per 100,000 men aged 0 to 39 years from 1999 to 2021 — the latest date available. First line of treatment for the disease is surgery, with doctors normally removing the tumor and testicle that is affected. Further tests are then carried out to establish whether the disease has spread, before other treatments are offered like surgery to remove lymph nodes and chemotherapy. Among those to have previously battled the cancer is cyclist Lance Armstrong, who was diagnosed with the disease in 1996 at the age of 25 years, and five-time Olympic Gold Medalist Nathan Adrian, who was diagnosed at age 30 years. The 6ft 6in swimmer was diagnosed with stage two testicular cancer in December 2018 amid training for Tokyo 2020 — saying he went to doctors after feeling something swollen and hard in his scrotum. He had surgery to remove the tumor in his scrotum a few weeks later and, after further tests, also had a second surgery to remove some lymph nodes that were feared to also contain the cancer. He was back swimming a few weeks later, and said that he will now monitor for any new cancers via surveillance. In another case, JMichael Shipman revealed in 2018 that he had been diagnosed with testicular cancer at the age of 21 years. The Texas local said he booked into MD Anderson Cancer Center after finding a large lump on his right testicle in February 2017. Two days later he was put through for surgery, and then had one round of chemotherapy. He also froze his sperm before the chemotherapy after being told that the regimen could make a man infertile for up to two years. It isn't clear whether he's now had children. The Ohio State University survey was conducted between May 2 and 5 this year using the SSRS Opinion Panel Omnibus, a twice-monthly survey of a representative sample of the US public. Of the respondents, 978 filled in answers to the questions via the web while 30 responded via the telephone.
Reuters
an hour ago
- Reuters
US CDC official in charge of COVID, RSV data resigns ahead of vaccine meeting
CHICAGO, June 16 (Reuters) - A U.S. government scientist who oversees the team responsible for collecting data on COVID-19 and RSV hospitalizations used to shape national vaccine policy has resigned, citing concerns over how such data would be used by the Trump administration. The scientist, Dr. Fiona Havers, told colleagues at the Centers for Disease Control and Prevention on Monday that she no longer had confidence that the COVID and RSV data would be used "objectively or evaluated with appropriate scientific rigor to make evidence-based vaccine policy decisions," according to an email seen by Reuters. Havers, leader of the RESP-NET Hospitalization Surveillance Team, and the CDC did not immediately respond to requests for comment. Her resignation follows moves by Health Secretary Robert Kennedy Jr. to abruptly fire all 17 members of the CDC's independent vaccine advisory panel and drop a recommendation for administering COVID shots to healthy children and pregnant women. Kennedy, who has long sown doubt about the safety and efficacy of vaccines, replaced the advisory board with eight members of his own choosing, some of whom have histories of objecting to COVID shots or vaccines in general. Havers said in her email that the COVID and RSV data collected by her team had been used in more than 20 peer-reviewed manuscripts and 15 Morbidity and Mortality Weekly Reports issued by the CDC. The newly installed vaccine panel, known as the Advisory Committee on Immunization Practices, is expected to meet June 25-27 to vote on the use of COVID-19 boosters and other vaccines by the American public.
